Vascular endothelial growth factor inhibitors and cognitive impairment: evidence and controversies

Author： Ng Terence   Cheung Yin Ting   Ng Quan Sing   Ho Han Kiat   Chan Alexandre  

Publisher： Informa Healthcare

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.13, Iss.1, 2014-01, pp. : 83-92

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vascular endothelial growth factor tyrosine kinase inhibitors

By  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 6, 2004-06 ,pp. : 921-924

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors targeting vascular endothelial growth factor receptor kinases and cyclin-dependent kinases

By  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 3, 2005-03 ,pp. : 337-341

Informa Healthcare

Access to resources Recommend Favorite

Development of Vascular Endothelial Growth Factor Receptor (VEGFR) Kinase Inhibitors as Anti-Angiogenic Agents in Cancer Therapy

By  

Current Medicinal Chemistry, Vol. 11, Iss. 6, 2004-03 ,pp. : 731-745

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Development of Angiogenesis Inhibitors to Vascular Endothelial Growth Factor and Its Receptors as Cancer Therapeutics

By  

Current Cancer Drug Targets, Vol. 2, Iss. 2, 2002-06 ,pp. : 135-156

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting vascular endothelial growth factor in angina therapy

By Boodhwani Munir   Ramlawi Basel   Laham Roger J   Sellke Frank W  

Expert Opinion on Therapeutic Targets, Vol. 10, Iss. 1, 2006-02 ,pp. : 5-14

Informa Healthcare

Access to resources Recommend Favorite